Crossmark

Protein Biomarkers in Lung Cancer Screening: Technical Considerations and Feasibility Assessment

Crossref DOI link: https://doi.org/10.1016/j.arbres.2024.07.007

Published Print: 2024-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Orive, Daniel

Echepare, Mirari

Bernasconi-Bisio, Franco

Sanmamed, Miguel Fernández

Pineda-Lucena, Antonio

de la Calle-Arroyo, Carlos

Detterbeck, Frank

Hung, Rayjean J.

Johansson, Mattias

Robbins, Hilary A.

Seijo, Luis M.

Montuenga, Luis M.

Valencia, Karmele
Funding

Funding for this research was provided by:

Biomedical Research Network Centre in Cancer (CB16/12/00443)

Spanish Association Against Cancer Scientific Foundation

Government of Spain Ministry of Universities (FPU20/06292)

National Cancer Institute (U19CA203654)

National Cancer Institute (R01CA262164)

Carlos III Health Institute

European Regional Development Fund (PI22/00451)

Consejería de Salud y Familias, Junta de Andalucía
License Information

Text and Data Mining valid from 2024-10-01

Text and Data Mining valid from 2024-10-01

Version of Record valid from 2024-07-17
More Information

This article is maintained by: Elsevier

Article Title: Protein Biomarkers in Lung Cancer Screening: Technical Considerations and Feasibility Assessment

Journal Title: Archivos de Bronconeumología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.arbres.2024.07.007

Content Type: article

Copyright: © 2024 The Authors. Published by Elsevier España, S.L.U. on behalf of SEPAR.